OZURDEX® is a biodegradable implant containing the corticosteroid dexamethasone. Corticosteroids, such as dexamethasone, block chemical pathways that lead to inflammation, leakage from the retinal blood vessels, and edema (swelling) of the retina. OZURDEX® may help reverse some vision loss that may be caused by a retinal vein occlusion (RVO) or by noninfectious uveitis affecting the posterior segment of the eye.
OZURDEX® reduces swelling of the macula

Click image to enlarge
The first and only injectable, biodegradable dexamethasone implant

A biodegradable implant is one that doesn't need to be removed after it's done working. OZURDEX® biodegradable implants use advanced NOVADUR® drug delivery technology, in which biodegradable material is combined with the active drug dexamethasone to form a tiny rod-shaped implant. Inside the eye, the implant is slowly dissolved in the vitreous gel that fills the eye, releasing dexamethasone.

Special considerations for corticosteroids

Corticosteroids, such as OZURDEX® intravitreal implants, can cause the fluid pressure inside the eye to increase. This is not something you can feel. So, following the injection, your doctor should monitor your eye pressure. If you experience this side effect, treatment such as medicated eyedrops or surgery may be required to lower the pressure.

Some patients who receive OZURDEX® intravitreal implants may develop cataracts or their existing cataracts may worsen. It's important to remember that not treating your condition may lead to irreversible vision loss. You should discuss this issue with your doctor.


Click the buttons below to learn about safety or see frequently asked questions about OZURDEX®: